NATALIE GMITER: Open Payments
NPI 1245011667 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 89 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,357 · 2025 $1,962
Food & beverage: $1,872Education: $90
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $457 |
| ABBVIE INC. | 16 | $243 |
| AstraZeneca Pharmaceuticals LP | 10 | $239 |
| UCB, Inc. | 10 | $235 |
| Janssen Biotech, Inc. | 8 | $223 |
| GlaxoSmithKline, LLC. | 6 | $147 |
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| Radius Health, Inc. | 4 | $76 |
| Fresenius Kabi USA, LLC | 3 | $65 |
| ANI Pharmaceuticals, Inc. | 2 | $47 |
Products named: SAPHNELO, TREMFYA, RINVOQ, EVENITY, Bimzelx, UPLIZNA, BENLYSTA, COSENTYX.
Industry payments across PA — which companies pay providers there.
